Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

Myriad Genetics (NASDAQ: MYGN), a leader in genetic testing and precision medicine, has announced its participation in two upcoming investor healthcare conferences. The company's management will be featured in fireside chats at:

The Wells Fargo Healthcare Conference on Sept. 4, 2024, at 1:30pm ET, with CFO Scott Leffler
The Morgan Stanley Healthcare Conference on Sept. 5, 2024, at 7:00am ET, with President and CEO Paul J. Diaz

Investors and interested parties can access live and archived webcasts of both presentations through the company's investor relations website at investor.myriad.com.

08/21/2024 - 08:00 AM

SALT LAKE CITY, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Myriad management will participate in two upcoming investor healthcare conferences.

The Wells Fargo Healthcare Conference in a fireside chat featuring Scott Leffler, Chief Financial Officer, on Sept. 4, 2024 at 1:30pm ET.
The Morgan Stanley Healthcare Conference in a fireside chat featuring Paul J. Diaz, President and CEO, on Sept. 5, 2024 at 7:00am ET.

Links to the live and archived webcasts of both presentations can be viewed at investor.myriad.com.

About Myriad Genetics
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.

Investor Contact
Matt Scalo
(801) 584-3532
IR@myriad.com

Media Contact
Glenn Farrell
(385) 318-3718
PR@myriad.com

FAQ

When is Myriad Genetics (MYGN) participating in the Wells Fargo Healthcare Conference?

Myriad Genetics (MYGN) is participating in the Wells Fargo Healthcare Conference on September 4, 2024, at 1:30pm ET.

Who will represent Myriad Genetics (MYGN) at the Morgan Stanley Healthcare Conference?

Paul J. Diaz, President and CEO of Myriad Genetics (MYGN), will represent the company at the Morgan Stanley Healthcare Conference on September 5, 2024, at 7:00am ET.

How can investors access the webcasts of Myriad Genetics (MYGN) conference presentations?

Investors can access live and archived webcasts of Myriad Genetics (MYGN) conference presentations through the company's investor relations website at investor.myriad.com.